Halozyme
S&P 400
$107.20
+0.19%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 25.9 times.
- Return on equity is healthy at 220.8%.
- Return on capital employed is healthy at 19.5%.
- Net profit margin is strong at 22.7%.
- Current assets comfortably cover current liabilities (current ratio 4.66).
!Watch-points
- Higher leverage: debt-to-equity of 14.93 is above 1.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
4.72
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Piotroski F-ScoreModerate
4 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$12.17B
Current Price$ 107.20
High / Low$ 111.15 / 61.23
Stock P/E31.436949
Book Value$ 1.18
Dividend Yield0%
ROCE19.54%
ROE220.76%
Debt to Equity14.93
Current Ratio4.66
P/B Ratio85.14694
EPS$ 2.56
Debt$2.14B
PAT Margin22.69%
Cash PAT$328.28M
ICR25.87